Go to the profile of C-Bridge Capital

C-Bridge Capital

 
  • China

About C-Bridge Capital

C-Bridge Capital is a healthcare dedicated private equity firm, focused on growth and late stage investment opportunities with US$800 million of Assets Under Management. C-Bridge Capital’s current portfolio includes China’s leading players in pharmaceuticals, medical devices, diagnostics and healthcare services. C-Bridge Capital is committed to support commercialization of cutting edge technologies and companies that fulfil unmet medical needs, thus continuously improving the standard and quality of care for patients.

Therapeutic Areas

Autoimmune disorders Blood and associated organs Cardiovascular Gastrointestinal Hepatic Infectious Inflammation Oncology Renal Respiratory

Technologies

Antimicrobial Biologics Biosimilars Diagnostics Medical device Small molecules Surgery Vaccines

Company Type

Investor

State of Ownership

Private

Sponsorship Group

Partner

Influencer Of

Topics

Editions participated in:

June 2018